Korro Bio Profit Margin

The latest profit margin for KRRO is -4477.08% as of June 2026. That compares with -1454.47% in the prior-year period — down 207.8% year over year. That is below the Healthcare sector average of 13.71%. Investors often review this figure alongside Korro Bio's historical trend and sector peers before judging valuation or financial health.

Over the past year, KRRO's profit margin moved from -1454.47% to -4477.08% — a 207.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Korro Bio's valuation or profitability profile.

Against Healthcare companies, KRRO currently prints -4477.08% for profit margin, while the sector average sits near 13.71%. That is roughly 32753.6% below the sector mean. Large gaps often invite a closer look at Korro Bio's growth, margins, and balance sheet.

Profit Margin shows how effectively Korro Bio converts resources into returns. At -4477.08%, KRRO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1454.47% in the prior-year period — down 207.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting KRRO's profit margin (-4477.08%), review year-over-year change from -1454.47%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.